Purchase Order 75D30120P09529
Award Date 9/3/20
Potential Completion Date 4/15/21
Potential Value $119K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Beaverton, OR 97008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Sedia Biosciences Corporation, doing business as Sedia Biosciences Corp, for the provision of Asante HIV-1 Rapid Recency Assay kits. The $77,950.00 contract supports CDC disease surveillance and prevention initiatives, with the kits being delivered to the CDC's Pittsburgh, Pennsylvania facility. Sedia Biosciences Corp has previously received over $350,000 in CDC purchase orders for similar...
- This federal contract award is for $149,825.00 in laboratory supplies and equipment to support disease monitoring and prevention programs at the Centers for Disease Control and Prevention (CDC). The prime contractor is Sedia Biosciences Corporation, doing business as Sedia Biosciences Corp, a privately held medical device and diagnostics company that provides laboratory supplies and equipment. The award includes firm fixed price purchase orders for rapid HIV recency assay kits, laboratory...
- The Centers for Disease Control and Prevention (CDC) awarded an $82,263 firm fixed price purchase order to Sedia Biosciences Corporation for laboratory supplies and equipment to support rapid recency kits. Sedia Biosciences, doing business as Sedia Biosciences Corp., will deliver the requested supplies and equipment from its location in Chamblee, Georgia to support CDC programs in Pittsburgh, Pennsylvania by December 30, 2023. No subcontractors or set aside designations were identified. The...
- The Centers for Disease Control and Prevention (CDC) awarded a $31,206.40 firm fixed-price purchase order to Vela Diagnostics USA Inc. for Sentosa SQ HIV Genotyping Reagents Kits and consumables required to perform the FDA-approved Next Generation Sequencing (NGS) HIV-1 drug resistance assay. This sole-source award, issued on October 1, 2024, with an ultimate completion date of the same date, was made under FAR 13.106-1(b) authority, as Vela Diagnostics is the only manufacturer of these...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $91,758.84 firm fixed-price purchase order is for the delivery of HIV test kits and supplies. The contract does not have a set-aside designation and has an ultimate completion date of December 31, 2021. Life Technologies Corporation, as the prime contractor, is a leading provider of biomedical research and genetic...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a firm fixed-price purchase order to Premier Medical USA Corp on July 30, 2024, for the supply of SURE STATUS HIV-1 RECENCY TEST kits (25 tests per kit), with a contract ceiling value of $50,450. The contract is not associated with a set-aside designation and will be performed in Somerset, Franklin Township, New Jersey. As a civilian agency contract, this award supports the CDC's public health surveillance and HIV monitoring...
- This is a federal purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract, valued at $21,556.49, is for the provision of HIV Performance Panels, which are quality control tools used in clinical laboratories. The contract has a completion date of September 30, 2019 and a firm fixed price pricing type. This...
- The Centers for Disease Control and Prevention, under the Department of Health and Human Services, awarded a $16,070 firm fixed price purchase order to Miscellaneous Foreign Awardees for HAIN LIFESCIENCE GENOTYPE LINE PROBE ASSAY KITS AND REAGENTS. Performance will take place in Germany from September 26, 2023 through October 16, 2023. The award is likely associated with CDC's infectious disease diagnostic testing and surveillance programs. No subcontractors or set aside designations were...
- The Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order valued at $63,189.00 to Bio-Rad Laboratories, Inc. on August 26, 2024, for HIV diagnostic testing products and supplies. The contract deliverables include GS HIV-1/HIV-2 Plus O enzyme immunoassay kits, GEENIUS HIV 1/2 supplemental assay reagents for diagnostic testing, GEENIUS HIV 1/2 control materials (120 UI x 2), and GS HIV-1 Western blot test kits (40 tests), all intended for detection and...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $33,840 firm fixed-price purchase order to Sebia, Inc., a global leader in automated electrophoresis technologies, to provide medical equipment, reagents, consumables, testing services, and maintenance support. This award is not set aside and is part of Sebia's broader contract vehicles with the Department of Veterans Affairs (VA) and Department of Defense (DoD) to deliver its specialized clinical laboratory technologies....